Our current finding suggests that detection of PATJ expression may be used as an independent favorable prognostic factor for ccRCC patients and that PATJ should be further evaluated as a novel target for future control of ccRCC. The gene discussed is PATJ; the disease is nonpapillary renal cell carcinoma.